Trial Profile
A Randomized, Multi-dose, Controlled Trial Investigating the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 19 Jul 2016 Primary endpoint of mean change in HbA1c from baseline over week 20 has not been met, according to results published in the Diabetes Care.
- 19 Jul 2016 Results published in the Diabetes Care
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.